Explore the positions available across Oxford Science Enterprises

Vaccitech
Vaccitech

Vaccitech is a spin-out company from the University of Oxford’s Jenner institute, one of the oldest and most renowned vaccine research centres in the world. The company has been formed around two viral vector vaccines, one to prevent influenza and the other to treat prostate cancer. Viral vector vaccines are particularly good at treating some of the most recalcitrant illnesses. The underlying technology is built on years of experience perfecting viral vector vaccine technology across multiple indications. The company’s protected chimpanzee adenovirus technology is the best way to generate T-cell responses and thereby generate lasting cell-mediated immunity. The assets are already in the clinic with very promising initial results. The founders of the company are Professor Adrian Hill (Director of the Jenner Institute) and Professor Sarah Gilbert (Lead in influenza and MERS), who combine their exceptional scientific skills with regulatory and manufacturing experience. This autumn, Vaccitech will begin a phase IIB efficacy study for a universal influenza vaccine in the over 65 population, and an extended phase I prostate cancer trial.
vaccitech.co.uk
Oxford, UK
Inaccurate data? Flag it here.
Open jobs at Vaccitech
We only use strictly necessary, first-party cookies on this job board. These are cookies that are necessary to deliver this service to you, or are necessary for Oxford Science Enterprises to understand how it is being used. Read our Cookie Policy.